Baxter Biopharma Solutions Articles
Canada: Politicians Reassured Over HIV
17 June 1996
Bayer To Market GI's Factor IX In Europe
3 June 1996
Cash Call By Cantab For L25 Million
20 May 1996
Baxter Appointment
13 May 1996
Baxter Board Approves $30M China Investment
13 May 1996
US HIV Blood $640 Mill Offer "Too Low"
6 May 1996
Profits Rise 9% At Baxter International
6 May 1996
1995 A Turning Point For Genetics Institute
6 May 1996
US HIV Hemophiliacs Offered $640 Million Compensation
29 April 1996
US Firms' Strong 1st Qtr Lifts Share Prices
29 April 1996
Canadian Firms, Govts Accused Over HIV Blood
29 April 1996
Japanese Prefecture Penalizes Drug Firms
22 April 1996
Japanese Drug Law "Failed To Stop HIV Tragedy"
8 April 1996
Appointments At Ergo Science
25 March 1996
Baxter And Possis Alliance
25 March 1996
Baxter Appointment
25 March 1996
Fresenius On The Verge Of Major Changes
25 March 1996
More Restructuring At Bayer Despite Strong 1995
25 March 1996
Japanese HIV Blood: Companies Apologize
25 March 1996
Baxter And Inhale In Strategic Alliance
11 March 1996
Further Evidence That Breast Implants Are Safe
11 March 1996
EUROPE STOCK COMMENT
4 March 1996
Baxter Agrees To Settle Japan HIV Lawsuit
4 March 1996
Baxter Gives Up Fight For W R Grace's NMC Unit
4 March 1996
Baxter Appointment
26 February 1996
Beneficial Effects Of Baxter's Artificial Hemoglobin
19 February 1996
EUROPE STOCK COMMENT
19 February 1996
EUROPE STOCK COMMENT
12 February 1996
Playing For High Stakes In National Medical Battle
12 February 1996
Mixed Earnings But Strong Sales For US Companies
12 February 1996
Baxter Deal In Indonesia
5 February 1996
Baxter appointment
8 January 1996
French Social Security Reform In 1996
8 January 1996
Major M&As in 1995 As UK Industry Consolidates
8 January 1996
Baxter Healthcare appointment
4 December 1995
Binary Fission At Baxter Creates Two New Entities
4 December 1995
Progress Towards Goals By US BioPharma Firms
4 December 1995
Baxter Healthcare acquires PSICOR
27 November 1995
Baxter Appointments
20 November 1995
Managed Care: Its Development In Europe
20 November 1995
Glaxo Wellcome Revamps R&D To Treble Productivity
13 November 1995
US Drug Firms Perform Well In Third Quarter
6 November 1995
Clintec Salvia To Stop Making Infusion Sols
6 November 1995
Baxter Opens Its First Manufacturing Plant in China
23 October 1995
Baxter Healthcare: VWR Corp sale
2 October 1995
Baxter Acquires 100% Of Nextran
2 October 1995
Germany's Merck Consolidates US Laboratory Business
25 September 1995
Favorable Ruling For Genentech's rh Factor VIII: C Patent
4 September 1995
US Economic Slowdown Affects Larger Firms
7 August 1995
Baxter's Gammagard linked to hepatitis
31 July 1995
CellPro Challenged In CD34 Antibody Patent Dispute
31 July 1995
Recombinant Solution For Hemophilia B Patients
31 July 1995
Us approval for Baxter's BioStat 1000
3 July 1995
Numbers rise in breast-implant lawsuit
26 June 1995
Kathy White to Baxter
12 June 1995
E Merck Gains From Baxter Sale
29 May 1995
SangStat gets approval for Cross-Stat
29 May 1995
Cantab Puts Itself Up For Sale?
15 May 1995
EU Approval For Behringwerke/Armour Plasma Deal
10 April 1995
Cross-Species Transplants Nearing Reality?
3 April 1995
Cantab's Lead Compound Disappoints
6 March 1995
Hemosol Stock Boost On Clinical Trial OK
27 February 1995
Baxter Appointment
20 February 1995
US Quarterly Results Round-Up
20 February 1995
Baxter New Dialysis Machine
13 February 1995
Baxter Buys In Chile
13 February 1995
End Of Year Encouraging For US Companies
6 February 1995
1994 Transitional For R-PR With Better Second Half
6 February 1995
US Firms seek Ban On HIV Class action
6 February 1995
Isolex Stem-Cell Separator Approved In Europe
23 January 1995
Musical Chairs At Glaxo Research
2 January 1995
Baxter Projects Rosy Outlook For 1994
2 January 1995
Oligopoly The Future For The Pharma Industry
2 January 1995
SangStat To Develop Generic Ciclosporin
19 December 1994
Becton Dickinson Joins Singapore Plan
28 November 1994
Baxter Appointment
21 November 1994
Future Health Care Partnerships In Europe
21 November 1994
Lower Earnings For Some US Drugmakers In 3rd Qtr
7 November 1994
Significant Progress Achieved At Cantab
31 October 1994
Baxter Agreement
24 October 1994
Baxter Intl Sells Diagnostics Business
10 October 1994
SangStat Approval
10 October 1994
Singapore Aims As World Pharma Production Base
10 October 1994
Baxter, Columbia/HCA Healthcare Deal
3 October 1994
CellPro: Making Stem Cell Therapy A Reality
26 September 1994
Baxter Healthcare Trials
5 September 1994
DNX, Baxter Form Transplant Partnership
5 September 1994
Employment Implications Of Mergers, Restructuring
5 September 1994
SangStat Starts Ph III Thymoglobulin Study
22 August 1994
Baxter/Rhone-Poulenc HIV settlement
22 August 1994
Mixed Results From US Companies In 2nd Qtr
8 August 1994
GAMMAGARD ADVERSE REACTIONS
1 August 1994
Cantab Begins US Trial For LM-CD45
25 July 1994
BAXTER SIGNS TURKISH JOINT VENTURE
4 July 1994
- Elan makes "transformational" acquisitions and a divestment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
